Cart
sales@molnova.com
IFNAR-IN-1
CAS No. 844882-93-5
IFNAR-IN-1( IFN-alpha and IFNAR interaction inhibitor )
Catalog No. M16138 CAS No. 844882-93-5
IFNAR-IN-1 is a nonpeptidic, small molecule inhibitor of IFN-α and IFNAR interaction.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIFNAR-IN-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionIFNAR-IN-1 is a nonpeptidic, small molecule inhibitor of IFN-α and IFNAR interaction.
-
DescriptionIFNAR-IN-1 is a nonpeptidic, small molecule inhibitor of IFN-α and IFNAR interaction, specifically inhibits MVA-induced IFN-α responses by BM-pDCs with IC50 of 2-8 uM.
-
In Vitro——
-
In Vivo——
-
SynonymsIFN-alpha and IFNAR interaction inhibitor
-
PathwayImmunology/Inflammation
-
TargetInterferon Receptor
-
RecptorInterferon Receptor
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number844882-93-5
-
Formula Weight279.3993
-
Molecular FormulaC18H17NS
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCNCC1=CC=CC=C1SC2=C3C=CC=CC3=CC=C2
-
Chemical NameBenzenemethanamine, N-methyl-2-(1-naphthalenylthio)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Geppert T, et al. Angew Chem Int Ed Engl. 2012 Jan 2;51(1):258-61.
molnova catalog
related products
-
Anifrolumab
Anifrolumab（MEDI-546） is a potent type I interferon (IFN) receptor antagonist, a human monoclonal antibody that targets IFN.Anifrolumab inhibits the activity of type I interferon and is used for the prevention and treatment of systemic lupus erythematosus (SLE).
-
CP-28888
CP-28888 (CP 28888-27) is an interferon inducer, a lipoamine with antitumor activity.
-
IFN-α Receptor Recog...
IFN-α Receptor Recognition Peptide 1 is a peptide of IFN-α associated with receptor interactions.
